We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical (EMN) Hikes Prices of Choline Chloride
Read MoreHide Full Article
Eastman Chemical Company (EMN - Free Report) is raising prices of Choline Chloride effective Jan 1, 2019 or as contracts permit.
In North and Latin America, the company raises Choline Chloride, Feed Grade prices by 20 cents per lb and in Asia Pacific, by $50/MT. In Europe, Middle East and Africa (EMEA), the company is increasing prices of the same product by €45/MT.
Eastman Chemical is taking actions to hike selling prices of these products in the wake of higher operating costs.
Higher selling prices of most product lines contributed to revenue growth at the company’s Additives & Functional Products and Chemical Intermediates segments in the third quarter of 2018.
In a year’s time, shares of Eastman Chemical have outperformed the industry it belongs to. The stock has lost around 23.7% compared with the industry’s fall of 28%.
During third-quarter earnings call, Eastman Chemical noted that strong volume gains in the specialty businesses, disciplined cost management and a lower effective tax rate helped it achieve year-over-year adjusted earnings per share growth of 13% during the first nine months of 2018. The company continues to expect a year-over-year adjusted earnings per share rise of 10-14% for 2018. It also estimates to generate roughly $1.1 billion of free cash flow in 2018.
The company is focused on productivity and cost-cutting actions, which are aiding it to offset raw material cost inflation and other cost headwinds. In 2018, Eastman Chemical expects to deliver $100 million of savings under its cost-reduction program.
Eastman Chemical has been seeing a rise in raw materials costs, mostly in its chemical intermediates business as witnessed in the third quarter. Raw materials cost woe is anticipated to persist through the remainder of 2018. Nevertheless, the company’s productivity and price-hike actions are likely to enable it to offset the input cost pressure.
Eastman Chemical currently carries a Zacks Rank #3 (Hold). A few better-ranked stocks in the basic materials space are CF Industries Holdings, Inc. (CF - Free Report) , The Mosaic Company (MOS - Free Report) and Cameco Corporation (CCJ - Free Report) .
CF Industries has an expected earnings growth rate of 748% for the current year and a Zacks Rank #1 (Strong Buy). The stock has inched up 0.5% in the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Mosaic has an expected earnings growth rate of 75.2% for the current year and a Zacks Rank #2 (Buy). The company’s shares have rallied 22.8% in the past year.
Cameco has an expected earnings growth rate of 66.7% for the current year and a Zacks Rank #2. Its shares have gained 11.8% in a year’s time.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
Eastman Chemical (EMN) Hikes Prices of Choline Chloride
Eastman Chemical Company (EMN - Free Report) is raising prices of Choline Chloride effective Jan 1, 2019 or as contracts permit.
In North and Latin America, the company raises Choline Chloride, Feed Grade prices by 20 cents per lb and in Asia Pacific, by $50/MT. In Europe, Middle East and Africa (EMEA), the company is increasing prices of the same product by €45/MT.
Eastman Chemical is taking actions to hike selling prices of these products in the wake of higher operating costs.
Higher selling prices of most product lines contributed to revenue growth at the company’s Additives & Functional Products and Chemical Intermediates segments in the third quarter of 2018.
In a year’s time, shares of Eastman Chemical have outperformed the industry it belongs to. The stock has lost around 23.7% compared with the industry’s fall of 28%.
During third-quarter earnings call, Eastman Chemical noted that strong volume gains in the specialty businesses, disciplined cost management and a lower effective tax rate helped it achieve year-over-year adjusted earnings per share growth of 13% during the first nine months of 2018. The company continues to expect a year-over-year adjusted earnings per share rise of 10-14% for 2018. It also estimates to generate roughly $1.1 billion of free cash flow in 2018.
The company is focused on productivity and cost-cutting actions, which are aiding it to offset raw material cost inflation and other cost headwinds. In 2018, Eastman Chemical expects to deliver $100 million of savings under its cost-reduction program.
Eastman Chemical has been seeing a rise in raw materials costs, mostly in its chemical intermediates business as witnessed in the third quarter. Raw materials cost woe is anticipated to persist through the remainder of 2018. Nevertheless, the company’s productivity and price-hike actions are likely to enable it to offset the input cost pressure.
Eastman Chemical Company Price and Consensus
Eastman Chemical Company Price and Consensus | Eastman Chemical Company Quote
Zacks Rank & Stocks to Consider
Eastman Chemical currently carries a Zacks Rank #3 (Hold). A few better-ranked stocks in the basic materials space are CF Industries Holdings, Inc. (CF - Free Report) , The Mosaic Company (MOS - Free Report) and Cameco Corporation (CCJ - Free Report) .
CF Industries has an expected earnings growth rate of 748% for the current year and a Zacks Rank #1 (Strong Buy). The stock has inched up 0.5% in the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Mosaic has an expected earnings growth rate of 75.2% for the current year and a Zacks Rank #2 (Buy). The company’s shares have rallied 22.8% in the past year.
Cameco has an expected earnings growth rate of 66.7% for the current year and a Zacks Rank #2. Its shares have gained 11.8% in a year’s time.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>